SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549


FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934



August 25, 2016
-----------------
(Date of Report)

ALANCO TECHNOLOGIES, INC.
-------------------------
(Exact name of Registrant as specified in its charter)


0-9437
---------
(Commission File No.)

ARIZONA                        86-0220694
---------------------------     ---------------------------------
(State or other jurisdiction)    (IRS Employer Identification No.)



7950 E. ACOMA DRIVE, SUITE 111, SCOTTSDALE, ARIZONA  85260
-------------------------------------------------------
(Address of Principal Executive Office)       (Zip Code)


(480) 607-1010
----------------------------------------------------
(Registrant's telephone number, including area code)


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

(  ) Written communication pursuant to Rule 425 under the Securities Act
      (17 CFR 230.425)

(  ) Soliciting material pursuant to Rule 14a-12 under the Exchange Act
     (17 CFR 240.14a-12)

(  ) Pre-commencement communications pursuant to Rule 14d-2(b) under the
 Exchange Act (17 CFR 240.14d-2(b))

(  ) Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))


Item 8.01 Other Events

On August 22, 2016, the Company announced it is launching a behavioral health subsidiary.

Item 9.01 Financial Statement and Exhibits

99.1       Press Release dated August 22, 2016

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.



  Alanco Technologies, Inc.  
       
By:
/s/ John A. Carlson  
    Name:  John A. Carlson  
    Title:    Director, President & Chief Executive Officer  
 Date:  August 25, 2016